Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.

Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus

Mok, Chi Chiu, Ho, Ling Yin, Leung, Hoi Wah, Wong, Lap Gate·2010·Translational research

Abstract

The objective of this study is to evaluate the specificity and sensitivity of antinucleosome, anti-C1q, and anti-dsDNA antibodies for detecting concurrent disease activity in systemic lupus erythematosus (SLE). Consecutive patients were recruited for serological testing of anti-dsDNA, IgG-antinucleosome, IgG-anti-C1q, and complement levels. SLE disease activity was assessed by SLEDAI and physician's global assessment (PGA). The levels of these antibodies, complements, and disease activity scores were correlated. The specificity and sensitivity of these antibodies in detecting SLE activity was determined. We recruited 245 SLE patients (95% women, age 40.6 ± 12.2 years). The prevalence of positive anti-dsDNA, antinucleosome and anti-C1q antibodies was 55%, 44%, and 21%, respectively. All 3 antibodies correlated significantly with SLEDAI and PGA scores but were correlated inversely with complement levels (P < 0.001 in all). Titers of anti-dsDNA and anti-C1q, but not antinucleosome, correlated significantly with the renal SLEDAI score. The sensitivity of anti-dsDNA, antinucleosome, and anti-C1q for detecting the presence of active renal disease was 75%, 47%, and 53%, respectively. Anti-C1q had the highest specificity for active lupus renal disease (84%) followed by antinucleosome (57%) and the anti-dsDNA antibody (49%). The negative predictive value (NPV) of a negative anti-dsDNA and anti-C1q for active renal disease was 91%. For concurrent extrarenal SLE activity, the specificity was also highest with anti-C1q (83%). We conclude that antinucleosome does not perform better than anti-dsDNA for detecting concurrent SLE activity. The anti-C1q antibody, however, is more specific than anti-dsDNA for both active renal and extrarenal lupus. The absence of both anti-dsDNA and anti-C1q has a high NPV for renal activity.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.trsl.2010.07.009

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 28 references

Research works printed but not linked: 1

  1. Bruns, 2000, Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus, Arthritis Rheum, 43, 2307, 10.1002/1529-0131(200010)43:10<2307::AID-ANR19>3.0.CO;2-J · doi:10.1002/1529-0131(200010)43:10<2307::aid-anr19>3.0.co;2-j

Cited by

See all 56

Metadata

Authors
Mok, C. C., Ho, L. Y., Leung, H. W., & Wong, L. G.
Affiliations
Tuen Mun Hospital (CN)
Corresponding author
Mok, Chi Chiu
Venue
Translational research
Publisher
Elsevier BV
Published
2010-12
Volume
156
Issue
6
Pages
320-325
ISSN
  • 1878-1810 (ISSN-L)
  • 1931-5244
OpenAlex
W2004622563
Cited by
56
References
28
Citations by year
2025: 3 · 2024: 3 · 2023: 1 · 2022: 7 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 5 · 2017: 4 · 2016: 4 · 2015: 2 · 2014: 2 · 2013: 4 · 2012: 9
FWCI
4.02
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Translational research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
Keywords
systemic lupus erythematosus, anti-C1q antibodies, anti-nucleosome antibodies, anti-dsDNA antibodies, disease activity, lupus nephritis, complement levels, serological markers, sensitivity and specificity, negative predictive value
MeSH terms
Adult, Antibodies, Antinuclear, Cross-Sectional Studies, DNA, Female, Humans, Immunoglobulin G, Kidney Diseases, Lupus Erythematosus, Systemic, Male, Middle Aged, Predictive Value of Tests, Sensitivity and Specificity, Complement C1q

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. https://app.cochat.ai/papers/10.1016/j.trsl.2010.07.009
The paper
Mok, C. C., Ho, L. Y., Leung, H. W., & Wong, L. G. (2010). Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. Translational research. https://doi.org/10.1016/j.trsl.2010.07.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.